Type 2 inflammation is a defining feature of infection with parasitic worms (helminths), as well as being responsible for widespread suffering in allergies. Although both of these conditions exert a devastating global impact and lack effective vaccines or refined therapeutics, basic knowledge of the key cell types and mediators that control Type 2 immunity and inflammation is currently limited. Dendritic cells (DCs) are a highly specialised type of antigen presenting cell that can potently activate T cells and coordinate immune responses. However, surprisingly little is known about how DCs are activated and function in tissues such as the lung during Type 2 inflammation.
This project will address the key question of how the lung environment modulates the ability of DCs to activate and direct Type 2 inflammation. The focus of the project will be the helminth Schistosoma mansoni, the immune response to which is strongly Type 2 biased and intimately involved in the pathology that accompanies infection. Schistosomiasis is second only to malaria in terms of the number of deaths caused annually by a parasitic disease. However, the key cellular and molecular networks that comprise immunity, inflammation and tissue repair against invading larval schistosomes are still unclear, particularly in the lung. Central to the project will be use of murine models to delineate the role of the lung environment (including surfactant and mucus) in controlling pulmonary DC activation and function in response to lung stage S. mansoni, with complementary work using allergens such as house dust mite.
This project will reveal exciting new information about the core mechanisms involved in coordination of pulmonary Type 2 inflammation by DCs, which may help future design of innovative therapies and vaccines for both helminth infection and allergies.
Training/techniques to be provided:
The successful candidate will receive training in a range of cutting-edge immunological techniques used in the MacDonald and Allen labs, including multi-parameter flow cytometry and mass cytometry (CyTOF), as well as gaining significant experience in in vivo models of inflammation, infection and allergy. Additional approaches such as refined isolation of immune cells from tissues, quantitative PCR, confocal microscopy and ELISA will also be used to define the activation and function of pulmonary DCs ex vivo and in vitro.
Candidates are expected to hold (or be about to obtain) a minimum upper second class honours degree (or equivalent) in Immunology or a closely related area/subject. Candidates with experience in cellular immunology or with an interest in mechanistic understanding of inflammation during helminth infection and/or allergic disease are encouraged to apply.
How To Apply
For information on how to apply for this project, please visit the Faculty of Biology, Medicine and Health Doctoral Academy website (https://www.bmh.manchester.ac.uk/study/research/apply/). Informal enquiries may be made directly to the primary supervisor. On the online application form select the appropriate subject title.
For international students, we also offer a unique 4 year PhD programme that gives you the opportunity to undertake an accredited Teaching Certificate whilst carrying out an independent research project across a range of biological, medical and health sciences.
Equality, Diversity and Inclusion
Equality, diversity and inclusion is fundamental to the success of The University of Manchester, and is at the heart of all of our activities. The full Equality, diversity and inclusion statement can be found on the website https://www.bmh.manchester.ac.uk/study/research/apply/equality-diversity-inclusion/”